Having observed the trajectory of hundreds of patients, from high-performance athletes to executives just trying to buy back a decade of vitality, a clear pattern emerges
However, development was discontinued in 2007 after the largest Phase IIb trial failed to demonstrate statistically significant weight loss compared to placebo
Diabetic neuropathy Peripheral neuropathy Up to 50% of diabetic patients develop peripheral neuropathy, a type of nerve damage that may result in pain, loss of sensation, and weakness, particularly in the lower extremities (67)
A major challenge is the difficulty in accurately assessing and validating their effects, given the complex interactions between different nutrients and individual variations in diet and genetics
Dihexa, a synthetic peptide known as N-hexanoic-Tyr-Ile-(6) aminohexanoic amide, has demonstrated potential benefits in protecting against hearing and memory loss